This is the authors' abstract. We don't add key points for this paper.
Stem and progenitor cell-based regenerative therapies have the potential to cure chronic respiratory diseases. Yan et al. 1 reported a clinical trial of autologous P63 + progenitor cell transplantation in bronchiectasis patients, highlighting autologous transplantation of P63 + progenitor cells as a novel candidate therapeutic option to improve pulmonary gas exchange function and quality of life. Stem and progenitor cell-based regenerative therapies have the potential to cure chronic respiratory diseases. Yan et al. reported a clinical trial of autologous P63 + progenitor cell transplantation in bronchiectasis patients, highlighting autologous transplantation of P63 + progenitor cells as a novel candidate therapeutic option to improve pulmonary gas exchange function and quality of life.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Yue et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: